PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LFMD vs. BVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LFMD and BVS is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

LFMD vs. BVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LifeMD, Inc. (LFMD) and Bioventus Inc. (BVS). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
48.68%
0.72%
LFMD
BVS

Key characteristics

Sharpe Ratio

LFMD:

0.08

BVS:

1.73

Sortino Ratio

LFMD:

0.70

BVS:

2.73

Omega Ratio

LFMD:

1.08

BVS:

1.34

Calmar Ratio

LFMD:

0.07

BVS:

1.51

Martin Ratio

LFMD:

0.13

BVS:

8.12

Ulcer Index

LFMD:

46.90%

BVS:

14.73%

Daily Std Dev

LFMD:

80.65%

BVS:

69.12%

Max Drawdown

LFMD:

-96.24%

BVS:

-95.18%

Current Drawdown

LFMD:

-75.38%

BVS:

-48.20%

Fundamentals

Market Cap

LFMD:

$336.47M

BVS:

$674.60M

EPS

LFMD:

-$0.64

BVS:

-$0.61

Total Revenue (TTM)

LFMD:

$135.08M

BVS:

$419.64M

Gross Profit (TTM)

LFMD:

$128.98M

BVS:

$281.75M

EBITDA (TTM)

LFMD:

-$10.22M

BVS:

$17.95M

Returns By Period

In the year-to-date period, LFMD achieves a 51.92% return, which is significantly higher than BVS's -5.24% return.


LFMD

YTD

51.92%

1M

45.45%

6M

48.62%

1Y

5.62%

5Y*

61.02%

10Y*

22.41%

BVS

YTD

-5.24%

1M

-2.74%

6M

0.71%

1Y

126.65%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LFMD vs. BVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LFMD
The Risk-Adjusted Performance Rank of LFMD is 4949
Overall Rank
The Sharpe Ratio Rank of LFMD is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 5151
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 4949
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 5050
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 4747
Martin Ratio Rank

BVS
The Risk-Adjusted Performance Rank of BVS is 8888
Overall Rank
The Sharpe Ratio Rank of BVS is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of BVS is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BVS is 8686
Omega Ratio Rank
The Calmar Ratio Rank of BVS is 8686
Calmar Ratio Rank
The Martin Ratio Rank of BVS is 8888
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LFMD vs. BVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for LifeMD, Inc. (LFMD) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LFMD, currently valued at 0.08, compared to the broader market-2.000.002.000.081.73
The chart of Sortino ratio for LFMD, currently valued at 0.70, compared to the broader market-4.00-2.000.002.004.006.000.702.73
The chart of Omega ratio for LFMD, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.34
The chart of Calmar ratio for LFMD, currently valued at 0.07, compared to the broader market0.002.004.006.000.071.51
The chart of Martin ratio for LFMD, currently valued at 0.13, compared to the broader market-10.000.0010.0020.0030.000.138.12
LFMD
BVS

The current LFMD Sharpe Ratio is 0.08, which is lower than the BVS Sharpe Ratio of 1.73. The chart below compares the historical Sharpe Ratios of LFMD and BVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
0.08
1.73
LFMD
BVS

Dividends

LFMD vs. BVS - Dividend Comparison

Neither LFMD nor BVS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LFMD vs. BVS - Drawdown Comparison

The maximum LFMD drawdown since its inception was -96.24%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for LFMD and BVS. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%SeptemberOctoberNovemberDecember2025February
-75.38%
-48.20%
LFMD
BVS

Volatility

LFMD vs. BVS - Volatility Comparison

LifeMD, Inc. (LFMD) has a higher volatility of 20.20% compared to Bioventus Inc. (BVS) at 9.61%. This indicates that LFMD's price experiences larger fluctuations and is considered to be riskier than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
20.20%
9.61%
LFMD
BVS

Financials

LFMD vs. BVS - Financials Comparison

This section allows you to compare key financial metrics between LifeMD, Inc. and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab